World's Best Scientists 2026 revealed!
Wolfgang L. Gross

Wolfgang L. Gross

D-Index & Metrics

Immunology

D-Index
97
Citations
39684
World Ranking
811
National Ranking
52

Medicine

D-Index
103
Citations
43005
World Ranking
7308
National Ranking
411

Wolfgang L. Gross publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Wolfgang L. Gross sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 450 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Wolfgang L. Gross D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Wolfgang L. Gross sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 97 D-Index — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Wolfgang L. Gross is affiliated with the University of Lübeck in Germany. The primary focus of their scholarly work spans several fields including Corporate Governance and Law, Vasculitis and related conditions, Otitis Media and Relapsing Polychondritis, Coagulation, Bradykinin, Polyphosphates, and Angioedema, as well as Genomics, phytochemicals, and oxidative stress. Their research also touches upon Mast cells and histamine and Garlic and Onion Studies.

Gross has authored multiple papers, published mainly in reputable venues such as "Die Aktiengesellschaft," "UNC Libraries," and "Frontiers in Immunology." Notable recent papers include:

  • "2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides" (2020, UNC Libraries)
  • "Corrigendum: Sulforaphane promotes dendritic cell stimulatory capacity through modulation of regulatory molecules, JAK/STAT3- and microRNA-signaling" (2022, Frontiers in Immunology)
  • "Wann ist der Bezugsrechtsausschluss bei sog. 'Spitzen' bei einer Kapitalerhöhung erforderlich und wann ist er gerechtfertigt?" (2021, Die Aktiengesellschaft)
  • "Geschlechter- und Frauenquote für Vorstand und Aufsichtsrat nach dem FüPoG II - Ab wann anzuwenden und ab wann berichtspflichtig?" (2021, Die Aktiengesellschaft)
  • "ESG-Studie: Unternehmen im Transformationsprozess" (2022, Die Aktiengesellschaft)

Frequent collaborators in their research include J. Charles Jennette, Ronald J. Falk, P. J. Bacon, Neil Basu, and M. Cinta Cid.

Gross' contributions also extend into book publications, including the forthcoming title "Handbuch börsennotierte AG," expected in 2025 with Verlag Dr. Otto Schmidt eBooks.

Best Publications

  • 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides

    J. C. Jennette;R. J. Falk;P. A. Bacon;N. Basu

  • A Randomized Trial of Maintenance Therapy for Vasculitis Associated with Antineutrophil Cytoplasmic Autoantibodies

    David Jayne;Niels Rasmussen;Konrad Andrassy;Paul Bacon

  • EULAR Recommendations for the management of primary small and medium vessel vasculitis

    C. Mukhtyar;L. Guillevin;M. C. Cid;B. Dasgupta

  • Genetically Distinct Subsets within ANCA-Associated Vasculitis

    Paul A Lyons;Tim F Rayner;Sapna Trivedi;Julia U Holle

  • Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis: a randomized trial.

    Kirsten de Groot;Lorraine Harper;David R.W. Jayne;Luis Felipe Flores Suarez

  • Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody–associated vasculitis

    Kirsten De Groot;Niels Rasmussen;Paul A Bacon;Jan Willem Cohen Tervaert

  • An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.

    Eva Reinhold-Keller;Nadja Beuge;Ute Latza;Kirsten De Groot

  • Anticytoplasmic autoantibodies: their immunodiagnostic value in Wegener granulomatosis.

    Bernhard Nolle;Ulrich Specks;Jens Lüdemann;Michael S. Rohrbach

  • EULAR recommendations for the management of large vessel vasculitis

    C. Mukhtyar;L. Guillevin;M. C. Cid;B. Dasgupta

  • EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis

    Bernhard Hellmich;Oliver Flossmann;Wolfgang L Gross;Paul Bacon

  • A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.

    Gary S. Hoffman;Maria C. Cid;David B. Hellmann;Loic Guillevin

  • Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme.

    J Lüdemann;B Utecht;W L Gross

  • Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.

    Matthieu Groh;Christian Pagnoux;Chiara Baldini;Elisabeth Bel

  • Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.

    C Mukhtyar;O Flossmann;B Hellmich;P Bacon

  • ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.

    W L Gross;W H Schmitt;E Csernok

  • Stable incidence of primary systemic vasculitides over five years: Results from the German vasculitis register

    Eva Reinhold-Keller;Karen Herlyn;Rosemarie Wagner-Bastmeyer;Wolfgang L. Gross

  • Effectiveness of TNF-alpha blockade with infliximab in refractory Wegener's granulomatosis

    P Lamprecht;J Voswinkel;T Lilienthal;B Nolle

  • Wegener's autoantigen decoded.

    D. E. Jenne;J. Tschopp;J. Lüdemann;B. Utecht

  • Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades

    Julia U. Holle;Wolfgang L. Gross;Ute Latza;Bernhard Nölle

  • A vasculitis centre based management strategy leads to improved outcome in eosinophilic granulomatosis and polyangiitis (Churg–Strauss, EGPA): monocentric experiences in 150 patients

    Frank Moosig;Jan Phillip Bremer;Bernhard Hellmich;Julia Ulrike Holle

  • Pulmonary Wegener's Granulomatosis : Correlation Between High-Resolution CT Findings and Clinical Scoring of Disease Activity

    Michael Reuter;Armin Schnabel;Frank Wesner;Kay Tetzlaff

Frequent Co-Authors

Elena Csernok
Elena Csernok University of Manchester
David Jayne
David Jayne University of Cambridge
Raashid Luqmani
Raashid Luqmani University of Oxford
Loïc Guillevin
Loïc Guillevin Université Paris Cité
Alfred Mahr
Alfred Mahr Université Paris Cité
Jörg T. Epplen
Jörg T. Epplen Ruhr University Bochum
Charles D. Pusey
Charles D. Pusey Imperial College London
Gary S. Hoffman
Gary S. Hoffman Cleveland Clinic
Ulrich Specks
Ulrich Specks Mayo Clinic
Vincenzo Cerundolo
Vincenzo Cerundolo University of Oxford

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology but seeking diverse career options, exploring related online degrees can open new doors. Nurse Practitioner programs, especially those known as easy nurse practitioner programs to get into, provide flexible pathways for healthcare professionals to expand their expertise while gaining clinical experience.

Mental health is a growing focus within healthcare, and the top pmhnp programs offer specialized psychiatric-mental health training. These programs emphasize clinical placements, ensuring students receive hands-on practice in real-world environments, a critical component for career success.

Cost is often a deciding factor when choosing a program. Many professionals find value in researching the cheapest psych np programs which balance affordability with quality education and opportunities for advancement.

Finally, understanding earning potential can guide career decisions. For example, insights into the highest paid dnp specialties highlight areas of nursing with the strongest financial rewards, helping graduates align their educational paths with long-term goals.

Best Scientists Citing Wolfgang L. Gross

Trending Scientists

Recently Published Articles